ScholarIQanswers from OpenAlex & ORCID
John H. Alexander
ResearcherPublications, citations & collaboration network
John H. Alexander is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does John H. Alexander have?
ScholarIQindexed works
John H. Alexander has 786 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does John H. Alexander have?
ScholarIQcitation count
John H. Alexander has 45,215 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of John H. Alexander?
ScholarIQh-index
John H. Alexander has an h-index of 106 in OpenAlex.
What is the i10-index of John H. Alexander?
ScholarIQi10-index
John H. Alexander has an i10-index of 364 in OpenAlex.
What is the ORCID of John H. Alexander?
ScholarIQorcid
The ORCID for John H. Alexander is on the source record.
What is the OpenAlex record for John H. Alexander?
ScholarIQopenalex
The OpenAlex for John H. Alexander is on the source record.
What are the most-cited papers on John H. Alexander?
ScholarIQmost cited works
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger, John H. Alexander, John J.V. McMurray, Renato D. Lópes, Elaine M. Hylek, Michael G. Hanna, Hussein R. Al‐Khalidi, Jack Ansell, Dan Atar, Álvaro Avezum, M. Cecilia Bahit, Rafael Díaz, J. Donald Easton, Justin A. Ezekowitz, Greg Flaker, David García, Margarida Geraldes, Bernard J. Gersh, Golitsyn Sp, Shinya Goto, Antonio G. Hermosillo, Stefan H. Hohnloser, John D. Horowitz, Puneet Mohan, Petr Janský, Basil S. Lewis, José López‐Sendón, Prem Pais, Alexander Parkhomenko, Freek W.A. Verheugt, Jun Zhu, Lars Wallentin
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation
Renato D. Lópes, Gretchen Heizer, Ronald Aronson, Amit N. Vora, Tyler Massaro, Roxana Mehran, Shaun G. Goodman, Stephan Windecker, Harald Darius, Jia Li, О. В. Аверков, M. Cecilia Bahit, Otávio Berwanger, Andrzej Budaj, Ziad Hijazi, Alexander Parkhomenko, Peter Sinnaeve, Robert F. Storey, Hölger Thiele, Dragoş Vinereanu, Christopher B. Granger, John H. Alexander
Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk
Julio Rosenstock, Vlado Perkovic, Odd Erik Johansen, Mark E. Cooper, Steven E. Kahn, Nikolaus Marx, John H. Alexander, Michael Pencina, Robert D. Toto, Christoph Wanner, Bernard Zinman, Hans J. Woerle, David Baanstra, Egon Pfarr, Sven Schnaidt, Thomas Meinicke, Jyothis T. George, Maximilian von Eynatten, Darren K. McGuire, for the CARMELINA Investigators
Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome
John H. Alexander, Renato D. Lópes, Stefan James, Rakhi Kilaru, Yaohua He, Puneet Mohan, Deepak L. Bhatt, Shaun G. Goodman, Freek W.A. Verheugt, Marcus Flather, Kurt Huber, Danny Liaw, Steen Husted, José López‐Sendón, Raffaele De Caterina, Petr Janský, Harald Darius, Dragoş Vinereanu, Jan H. Cornel, Frank Cools, Dan Atar, José L. Leiva-Pons, Mátyás Keltai, Hisao Ogawa, Prem Pais, Alexander Parkhomenko, Witold Rużyłło, Rafael Díaz, Harvey D. White, Mikhail Ruda, Margarida Geraldes, Jack Lawrence, Robert A. Harrington, Lars Wallentin
Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial
Stefan H. Hohnloser, Ziad Hijazi, Laine Thomas, John H. Alexander, John Amerena, Michael G. Hanna, Mátyás Keltai, Fernando Laņas, Renato D. Lópes, José López‐Sendón, Christopher B. Granger, Lars Wallentin